<DOC>
	<DOCNO>NCT00993538</DOCNO>
	<brief_summary>The main objective project well understanding human leukemic disease also find new anti-leukemic improve exist one . This study , follow aim : - To analyze genetic epigenetic regulation retinoic acid induce cascade lead expression TRAIL blood cell patient acute leukemia . This study complement analysis global gene expression ( DNA chip ) DNA methylation state , chromatin immunoprecipitation experience . - To determine efficiency inhibitor enzymes responsible modification chromatin ( exist new development within European consortium EPITRON coordinate Dr Gronemeyer ) inducer differentiation / apoptosis leukemic blast . - To explore Ikaros genic functional abnormality ( genomic deletion , mutation , abnormal transcript protein ) acute leukemia . The aim determine abnormality may play prognosis role .</brief_summary>
	<brief_title>Leukemia Cell Cultures Research New Anti-Cancer Therapies</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<criteria>Patients suspect de novo secondary relapse acute leukemia , require complementary blood test bone marrow analysis Patients old equal 28 day Informed consent sign Pregnancy Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Leukaemia</keyword>
	<keyword>Blood marrow cell culture</keyword>
	<keyword>Cell growth</keyword>
	<keyword>Cell differentiation</keyword>
</DOC>